Simultaneous Immobilization of Bioactives During 3D Powder Printing of Bioceramic Drug‐Release Matrices

Advanced Functional Materials (Impact Factor: 10.44). 04/2010; 20(10):1585 - 1591. DOI: 10.1002/adfm.200901759

ABSTRACT The combination of a degradable bioceramic scaffold and a drug-delivery system in a single low temperature fabrication step is attractive for the reconstruction of bone defects. The production of calcium phosphate scaffolds by a multijet 3D printing system enables localized deposition of biologically active drugs and proteins with a spatial resolution of approximately 300 µm. In addition, homogeneous or localized polymer incorporation during printing with HPMC or chitosan hydrochloride allows the drug release kinetics to be retarded from first to zero order over a period of 3–4 days with release rates in the range 0.68%–0.96% h−1. The reduction in biological activity of vancomycin, heparin, and rhBMP-2 following spraying through the ink jet nozzles is between 1% and 18%. For vancomycin, a further loss of biological activity following incorporation into a cement and subsequent in vitro release is 11%. While previously acknowledged as theoretically feasible, is its shown for the first time that bone grafts with simultaneous geometry, localized organic bioactive loading, and localized diffusion control are a physical reality. This breakthrough offers a new future for patients by providing the required material function to match patient bone health status, site of repair, and age.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Thermal effects and laser performances are reported for edge-pumped microchip Yb:YAG laser. Astigmatic and spherical thermal lens were measured. 135 W peak power in quasicontinuous operation with 10 Hz and 10% duty factor was obtained.
    Acta Biomaterialia - ACTA BIOMATER. 01/2003;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite (nano-HAP) composite porous scaffolds with well-controlled pore architectures as well as high exposure of the bioactive ceramics to the scaffold surface were fabricated via selective laser sintering. Neat PLGA and the composite of PLGA/nano-HAP were used to obtain suitable process parameters. The effects of nano-HAP content on the microstructure and mechanical properties were investigated. The testing results showed that the compressive strength and modulus of the scaffolds were highly enhanced when the nano-HAP content reached from 0 to 20 wt%, while the mechanical properties experienced a sharp dropped with the nano-HAP content further increased. This might be due to the large reduction in polymer which decreased the interface bond strength between particles. It suggests that the introduction of nano-HAP as a reinforcing phase can improve the mechanical properties of the polymer porous scaffolds. The novel developed scaffolds may serve as a three-dimensional bone substrate in tissue engineering.
    International Journal of Advanced Manufacturing Technology 01/2013; · 1.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Synthetic bone replacement materials are of great interest because they offer certain advantages compared with organic bone grafts. Biodegradability and preoperative manufacturing of patient specific implants are further desirable features in various clinical situations. Both can be realised by 3D powder printing. In this study, we introduce powder-printed magnesium ammonium phosphate (struvite) structures, accompanied by a neutral setting reaction by printing farringtonite (Mg(3)(PO(4))(2)) powder with ammonium phosphate solution as binder. Suitable powders were obtained after sintering at 1100°C for 5 h following 20-40 min dry grinding in a ball mill. Depending on the post-treatment of the samples, compressive strengths were found to be in the range 2-7 MPa. Cytocompatibility was demonstrated in vitro using the human osteoblastic cell line MG63.
    Journal of Materials Science Materials in Medicine 11/2010; 21(11):2947-53. · 2.14 Impact Factor


Available from
May 15, 2014